The Brazil Psoriasis Market size stood at USD 210 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Psoriasis is a non-communicable inflammatory skin condition that alters the life cycle of skin cells by speeding up the growth of cells on the skin’s surface. The rapid development of cells produces thick, silvery scales and makes the skin red, dry, flaky, and itchy. Currently, no permanent cure is available for the disease. However, preventative measures can be adopted to slow down skin cells’ growth on the surface of the skin.
Rapidly increasing geriatric population, growing prevalence of plaque psoriasis and psoriatic arthritis, this huge rise in psoriasis patients in the past few years can be mainly attributed to climate change, stress and unhealthy lifestyle.
Huge pipeline of biologic and biosimilar products, favourable reimbursement policies, and growing prescription volume of the biologic products are some of the other factors contributing the psoriasis treatment market growth.